Background There is a lack of contemporary data describing patients with left ventricular (LV) systolic dysfunction post ...
Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
Background A 64-year-old male was observed as an outpatient with atypical, non-exercise-induced chest pain and palpitations. He had arterial hypertension and marked concentric left ventricular ...
Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...
Background. A 54-year-old postmenopausal woman presented with retrosternal chest pressure, nausea, and vomiting of 4 h duration. Her medical history included hypertension (treated with metoprolol and ...
A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results